RIT1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.960800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.500200E-01
Normal-vs-Stage2
9.883400E-01
Normal-vs-Stage3
3.080600E-01
Normal-vs-Stage4
7.924600E-01
Stage1-vs-Stage2
4.796800E-01
Stage1-vs-Stage3
5.368600E-01
Stage1-vs-Stage4
3.211000E-01
Stage2-vs-Stage3
2.728000E-01
Stage2-vs-Stage4
8.285600E-01
Stage3-vs-Stage4
2.318400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.350200E-01
Normal-vs-AfricanAmerican
6.477400E-01
Normal-vs-Asian
8.837200E-01
Caucasian-vs-AfricanAmerican
3.693800E-01
Caucasian-vs-Asian
6.070000E-01
AfricanAmerican-vs-Asian
8.894400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.556000E-01
Normal-vs-Female
8.203600E-01
Male-vs-Female
6.070000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.224600E-01
Normal-vs-Age(41-60Yrs)
6.589600E-01
Normal-vs-Age(61-80Yrs)
7.573600E-01
Normal-vs-Age(81-100Yrs)
1.897410E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.752600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.001400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.130400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.006140E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.220070E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.298620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.365600E-01
Normal-vs-Daily Drinker
4.017800E-01
Normal-vs-Weekly Drinker
6.525800E-01
Normal-vs-Occasional Drinker
6.894200E-01
Normal-vs-Social Drinker
9.117200E-01
Non Drinker-vs-Daily Drinker
2.869000E-01
Non Drinker-vs-Weekly Drinker
7.552600E-01
Non Drinker-vs-Occasional Drinker
2.442200E-01
Non Drinker-vs-Social Drinker
7.997600E-01
Daily Drinker-vs-Weekly Drinker
5.030400E-01
Daily Drinker-vs-Occasional Drinker
2.656200E-02
Daily Drinker-vs-Social Drinker
1.743990E-01
Weekly Drinker-vs-Occasional Drinker
1.635020E-01
Weekly Drinker-vs-Social Drinker
5.473000E-01
Occasional Drinker-vs-Social Drinker
3.607400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.875000E-01
Normal-vs-Grade 2
1.015770E-01
Normal-vs-Grade 3
7.658200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.655900E-03
Grade 1-vs-Grade 3
1.890080E-02
Grade 1-vs-Grade 4
3.875000E-01
Grade 2-vs-Grade 3
2.472200E-01
Grade 2-vs-Grade 4
1.015770E-01
Grade 3-vs-Grade 4
7.658200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.213000E-01
Normal-vs-NonDiabetic
8.964200E-01
Diabetic-vs-NonDiabetic
6.470200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.191800E-01
Normal-vs-NoPancreatitis
8.349600E-01
Pancreatitis-vs-NoPancreatitis
3.320000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.588800E-01
Normal-vs-N1
9.763200E-01
N0-vs-N1
3.733800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.264000E-01
Normal-vs-TP53-NonMutant
7.780000E-01
TP53-Mutant-vs-TP53-NonMutant
8.986200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
